TPO agonist 1
2-(3,4-dimethylphenyl)-4-[[2-hydroxy-3-[3-(2H-tetrazol-5-yl)phenyl]phenyl]diazenyl]-5-methyl-1H-pyrazol-3-one
Molecular Identity
TPO agonist 1
2-(3,4-dimethylphenyl)-4-[[2-hydroxy-3-[3-(2H-tetrazol-5-yl)phenyl]phenyl]diazenyl]-5-methyl-1H-pyrazol-3-one
PubChem CID: 135451068
2D Structure
Properties
C25H22N8O2
Molecular Formula
466.50
Molecular Weight
g/mol
466.1866
Exact Mass
Da
5
XLogP
Above Lipinski threshold
132
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
8
H-Bond Acceptors
834
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
TPO agonist 11033040-23-1TPO-Agonist-1LGD-46652-(3,4-dimethylphenyl)-4-[[2-hydroxy-3-[3-(2H-tetrazol-5-yl)phenyl]phenyl]diazenyl]-5-methyl-1H-pyrazol-3-oneSCHEMBL164331SCHEMBL164332orb1706519SCHEMBL2868676CHEMBL3545303SCHEMBL13477376SCHEMBL29409485SCHEMBL30085672SCHEMBL30449509SCHEMBL31318274
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to TPO agonist 1
Loading drug network...